This selective sensitivity likely reflects a heightened dependency of these cells on MYC-driven signaling (‘oncogene addiction’), emphasizing the vulnerability of retinoblastoma cells primarily driven by MYCN amplification. This evidence concerns the gene MYCN and retinoblastoma.